Revenue from Contracts with Customers - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Revenues	$ 378,734	$ 319,946	$ 1,142,800	$ 942,430
Product revenue, net
Disaggregation of Revenue [Line Items]
Revenues	374,601	319,508	1,136,670	925,848
License and royalty revenues
Disaggregation of Revenue [Line Items]
Revenues	4,133	438	6,130	16,582
Total radiopharmaceutical oncology
Disaggregation of Revenue [Line Items]
Revenues	259,756	216,276	792,265	623,802
PYLARIFY
Disaggregation of Revenue [Line Items]
Revenues	259,756	215,428	791,881	621,419
Other radiopharmaceutical oncology
Disaggregation of Revenue [Line Items]
Revenues	0	848	384	2,383
Total precision diagnostics
Disaggregation of Revenue [Line Items]
Revenues	103,727	96,348	320,048	289,543
DEFINITY
Disaggregation of Revenue [Line Items]
Revenues	76,965	67,336	231,629	206,688
TechneLite
Disaggregation of Revenue [Line Items]
Revenues	20,480	23,272	70,380	65,853
Other precision diagnostics
Disaggregation of Revenue [Line Items]
Revenues	6,282	5,740	18,039	17,002
Strategic partnerships and other revenue
Disaggregation of Revenue [Line Items]
Revenues	$ 15,251	$ 7,322	$ 30,487	$ 29,085